$PLXS

Plexus Sets Fiscal Third Quarter 2026 Earnings Release Date

Plexus Corp. (NASDAQ: PLXS) said it will report fiscal third-quarter 2026 results after the market close on Wednesday, July 29, 2026. Management will hold an earnings conference call on Thursday, July 30, 2026 at 8:30 a.m. ET, with a webcast and slides available on Plexus’ investor relations site, and a 12-month replay.

Original reporting
Published Jul 15, 2026, 9:15 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 15, 2026, 9:22 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Plexus Sets Fiscal Third Quarter 2026 Earnings Release Date — source image
Decision brief

The 30-second read

$PLXSNeutralMed
01

Why it matters

The primary impact is event-driven volatility risk management around the after-close release and the next-morning call; without guidance or results, there is no directional fundamental signal.

02

Market read

Traders can plan options, hedges, and positioning around the July 29 after-close print and July 30 8:30 a.m. ET call.

03

What to watch

The article provides no numbers, so the main tradable edge is timing and liquidity around the event, not fundamental repricing from new information.

Relevance 5/10Novelty 5/10Timing: Ahead of the July 29 after-close earnings release and July 30 8:30 a.m. ET conference call.

Background

Plexus Corp. announced the date for its fiscal third quarter 2026 results and the associated earnings call/webcast.

Company-level read

Ticker impact

$PLXSNeutralMedium confidence
Context

Plexus (PLXS) set its fiscal Q3 2026 earnings release for July 29 after the close, with a call July 30 morning.

Expected impact

Likely elevated pre-earnings positioning and post-release volatility; direction depends on results versus expectations.

Evidence & confidence

The article discloses only the timing of the earnings event, not guidance, estimates, or any new operating datapoint.

Market effects

May increase near-term sentiment sensitivity for contract manufacturing and aerospace/defense and healthcare/life-sciences supply chains, but no sector datapoints are provided.

No specific regional market impact is described.

No global macro or international demand signals are included.

Counterpoint

Because the release date is already a known type of catalyst, traders may treat it as routine and focus only on any later pre-announcement guidance or analyst estimate changes.

Key entities

  • Plexus Corp.

    NASDAQ-listed contract manufacturer that scheduled its fiscal Q3 2026 earnings release and conference call.

Related articles

$PLXSHigh

PLEXUS CORP (PLXS): Results of Operations and Financial Condition

PLEXUS CORP (PLXS) filed an SEC Form 8-K — Results of Operations and Financial Condition. Plexus Announces Fiscal Third Quarter Financial Results NEENAH, WI – July 29, 2026 - Plexus Corp. (NASDAQ: PLXS) today announced financial results for our fiscal third quarter ended July 4, 2026, and guidance for our fiscal fourth quarter ending October 3, 2026. • Reports record

$PAHCMedAI 8/10

Phibro Animal Health (PAHC) Sets 2027 Guidance, Is The Stock Still A Bargain?

Phibro Animal Health (PAHC) issued 2027 guidance, projecting net sales of $1.55b-$1.60b and net income of $122m-$132m. The company reported 2026 sales of $1.518b and net income of $99.72m. Analysts' price targets range from $38 to $58, with a consensus of $45.60, suggesting a 16.1% undervaluation. The stock has seen a 90-day return of 17.95% and a 3-year return above 200%.

$HONMed

Honeywell Is Now Three Companies. Here's Which Piece I'd Actually Own.

Honeywell has split into three companies: Honeywell Technologies (HON), Solstice Advanced Materials (SOLS), and Honeywell Aerospace (HONA). Honeywell Technologies, led by CEO Vimal Kapur, reported strong automation sector growth with 16% order increase and 10% earnings growth. Solstice Advanced Materials showed 11% sales growth and 23% EPS increase, while Honeywell Aerospace lowered guidance.

$PATHMed

Why UiPath Stock Plunged Today

UiPath (NYSE: PATH) shares fell after its Q2 fiscal 2027 earnings, despite revenue growth of 13% to $410M and adjusted operating income up 43% to $89M. CEO Daniel Dines highlighted the company's strategy of using AI where it adds value. Analyst Kingsley Crane downgraded the stock to 'hold', citing competitive threats from AI-powered rivals like Salesforce.